Drug Profile
MBU 820
Alternative Names: OralexLatest Information Update: 16 Jul 2002
Price :
$50
*
At a glance
- Originator Molecular Biosystems
- Class Contrast media
- Mechanism of Action Ultrasonography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Gastrointestinal disorders
Most Recent Events
- 26 Jan 2001 Molecular Biosystems has been acquired by Alliance Pharmaceutical Corporation
- 29 Aug 1996 Phase-II clinical trials for Gastrointestinal disorders (diagnosis) in USA (PO)